Scott Rocklage is the Managing Partner of a company called 5AM Venture Management LLC. This company is a venture capital firm that specializes in drug development, medical technology, biopharmaceuticals, and other related areas. They assist with startup investments, seed, growth capital, and early-stage development. The company has a special interest in companies that are doing active research and development in the areas such as oncology, anti-infectives, diabetes, and other specialized areas. They are also very active in the field of medical technologies.
Scot Rocklage Ph.D. help to found the 5AM Ventures in 2003, and helped the company obtain FDA approval for Cubicin, Teslascan, and Omiscan. In addition to his work with 5AM Ventures, he is also working as the Chairman and CEO of Cubist Pharmaceuticals, Nycomed Salutar as the President and CEO, Chairman of the Board at Relypsa, Novira, and Achaogen.He also serves on the board for Pulmatrix and Epirus. He served as the Executive Chairman of a company acquired by Teleflex called Semprus, Ilypsa, and Miikana. He is also Chairman of the board for Novira which was eventually acquired by Johnson & Johnson, Rennovia, Cidara, and Kinestral.
Dr. Rocklage has worked in the healthcare industry for over 30 years. In an interview posted to Ideamensch, he jokes about the name of his company 5AM. It is in reference to the early stage of company formation and the name suggests an early time frame, just as they are involved with early business. On a given day, he may work in the field of science or investing. He usually works with a mix of business leaders, scientists, and physicians. He goes on to state his current interest in the field of cancer research and development. He says that he feels excited about being able to pinpoint certain mutations that would allow for a more effective cancer treatment.
Dr. Scott Rocklage attended the University of California, Berkley where he received a B.S. in Chemistry. He obtained his Ph.D. from the Massachusetts Institue of Technology in the field of Chemistry. He has published a large number of peer-reviewed papers and has 30 U.S. patents.
To learn more, visit http://5amventures.com/team/scott-m-rocklage-phd/.